The precision longevity and aging technology (agetech) diagnostics market size has grown rapidly in recent years. It will grow from $92.78 billion in 2025 to $107.21 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to rising prevalence of chronic age related diseases driving demand for early diagnostics, expansion of genomics and precision medicine research, increasing adoption of preventive healthcare practices, growth in healthcare digitization and electronic health records, rising investment in biotechnology and aging research studies.
The precision longevity and aging technology (agetech) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $188.35 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to advancement in ai powered predictive health analytics for aging assessment, increasing adoption of personalized longevity and preventive care models, growth in wearable biosensor technologies for continuous monitoring, expansion of multi omics based diagnostic platforms, rising integration of digital health ecosystems with clinical decision making systems. Major trends in the forecast period include increasing adoption of epigenetic age clocks for precise biological age measurement and healthspan tracking, growing use of ai driven biomarker analytics for early detection of age related diseases, expansion of multi omics integration including genomics proteomics and metabolomics for personalized longevity insights, rising demand for wearable based continuous health monitoring systems for real time aging assessment, increasing development of personalized preventive healthcare platforms focused on longevity optimization.
The increasing demand for preventive and personalized healthcare solutions is expected to accelerate the growth of the precision longevity and aging technology (AgeTech) diagnostics market in the forecast period. Preventive and personalized healthcare is an advanced healthcare approach focused on identifying disease risks early and providing customized medical strategies based on an individual’s specific biological characteristics, genetic information, and health conditions. The rising demand for preventive and personalized healthcare is driven by the need for early disease identification, which supports timely medical intervention and minimizes the progression of severe health conditions through personalized risk evaluation and targeted treatment approaches. Precision longevity and AgeTech diagnostics contribute to preventive and personalized healthcare by facilitating the early identification of age-related disorders and tracking biological aging indicators continuously, enabling proactive and individualized interventions to enhance long-term health outcomes. For instance, in July 2024, according to the United Nations Children's Fund (UNICEF), a US-based international organization providing humanitarian and developmental assistance to children globally, the worldwide share of adolescent girls receiving at least one dose of the HPV vaccine increased from 20% in 2022 to 27% in 2023, representing a 7-percentage-point improvement. Therefore, the rising demand for preventive and personalized healthcare is supporting the growth of the precision longevity and aging technology (AgeTech) diagnostics market.
Leading companies operating in the precision longevity and aging technology (AgeTech) diagnostics market are focusing on developing advanced artificial intelligence (AI)-driven biological age assessment solutions to improve the accuracy of aging measurements, enable personalized health interventions, and support proactive longevity management. AI-based biological age assessment refers to the use of machine learning algorithms and biomarker analysis to estimate an individual's biological age and aging rate, providing actionable insights for healthspan optimization. For example, in May 2024, NOVOS, a US-based longevity biotechnology company, launched a free AI-powered biological age test designed to provide highly accurate biological age estimations using advanced data analytics and aging science. The solution enables users to assess their rate of aging, gain personalized longevity recommendations, and track healthspan-related metrics, supporting more precise preventive healthcare and longevity-focused decision-making.
In June 2024, Longevity AI, an Israel-based health management and clinical platform company, entered into a partnership with Preventous Collaborative Health to accelerate AI-powered preventive care and personalized longevity-focused health management solutions. Through this collaboration, Longevity AI and Preventous Collaborative Health aim to combine AI-enabled health analytics with proactive, team-based preventive care to improve early risk identification, personalized health optimization, and longevity-centered clinical decision-making. Preventous Collaborative Health is a Canada-based provider of proactive, team-based preventive medicine, anti-aging, and Age Tech diagnostic services.
Major companies operating in the precision longevity and aging technology (agetech) diagnostics market report are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., Everly Health Inc., Neko Health AB, Genova Diagnostics Inc., Human Longevity Inc., Levels Health Inc., Fountain Life LLC, Viome Life Sciences Inc., Nightingale Health Plc, Elysium Health Inc., TruDiagnostic Inc., Occuity Limited, InsideTracker Inc., Gero PTE. Ltd., Chronomics Limited, BioAro Inc., Circulate Health Inc., MediPredict Medicine Pvt. Ltd., Prenuvo Inc., Longevity Care Partners, Genomind, ADNAB Inc.
North America was the dominating region in the precision longevity and aging technology (agetech) diagnostics market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the precision longevity and aging technology (agetech) diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision longevity and aging technology (agetech) diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
This product will be delivered within 3-5 business days.
The precision longevity and aging technology (agetech) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $188.35 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to advancement in ai powered predictive health analytics for aging assessment, increasing adoption of personalized longevity and preventive care models, growth in wearable biosensor technologies for continuous monitoring, expansion of multi omics based diagnostic platforms, rising integration of digital health ecosystems with clinical decision making systems. Major trends in the forecast period include increasing adoption of epigenetic age clocks for precise biological age measurement and healthspan tracking, growing use of ai driven biomarker analytics for early detection of age related diseases, expansion of multi omics integration including genomics proteomics and metabolomics for personalized longevity insights, rising demand for wearable based continuous health monitoring systems for real time aging assessment, increasing development of personalized preventive healthcare platforms focused on longevity optimization.
The increasing demand for preventive and personalized healthcare solutions is expected to accelerate the growth of the precision longevity and aging technology (AgeTech) diagnostics market in the forecast period. Preventive and personalized healthcare is an advanced healthcare approach focused on identifying disease risks early and providing customized medical strategies based on an individual’s specific biological characteristics, genetic information, and health conditions. The rising demand for preventive and personalized healthcare is driven by the need for early disease identification, which supports timely medical intervention and minimizes the progression of severe health conditions through personalized risk evaluation and targeted treatment approaches. Precision longevity and AgeTech diagnostics contribute to preventive and personalized healthcare by facilitating the early identification of age-related disorders and tracking biological aging indicators continuously, enabling proactive and individualized interventions to enhance long-term health outcomes. For instance, in July 2024, according to the United Nations Children's Fund (UNICEF), a US-based international organization providing humanitarian and developmental assistance to children globally, the worldwide share of adolescent girls receiving at least one dose of the HPV vaccine increased from 20% in 2022 to 27% in 2023, representing a 7-percentage-point improvement. Therefore, the rising demand for preventive and personalized healthcare is supporting the growth of the precision longevity and aging technology (AgeTech) diagnostics market.
Leading companies operating in the precision longevity and aging technology (AgeTech) diagnostics market are focusing on developing advanced artificial intelligence (AI)-driven biological age assessment solutions to improve the accuracy of aging measurements, enable personalized health interventions, and support proactive longevity management. AI-based biological age assessment refers to the use of machine learning algorithms and biomarker analysis to estimate an individual's biological age and aging rate, providing actionable insights for healthspan optimization. For example, in May 2024, NOVOS, a US-based longevity biotechnology company, launched a free AI-powered biological age test designed to provide highly accurate biological age estimations using advanced data analytics and aging science. The solution enables users to assess their rate of aging, gain personalized longevity recommendations, and track healthspan-related metrics, supporting more precise preventive healthcare and longevity-focused decision-making.
In June 2024, Longevity AI, an Israel-based health management and clinical platform company, entered into a partnership with Preventous Collaborative Health to accelerate AI-powered preventive care and personalized longevity-focused health management solutions. Through this collaboration, Longevity AI and Preventous Collaborative Health aim to combine AI-enabled health analytics with proactive, team-based preventive care to improve early risk identification, personalized health optimization, and longevity-centered clinical decision-making. Preventous Collaborative Health is a Canada-based provider of proactive, team-based preventive medicine, anti-aging, and Age Tech diagnostic services.
Major companies operating in the precision longevity and aging technology (agetech) diagnostics market report are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., Everly Health Inc., Neko Health AB, Genova Diagnostics Inc., Human Longevity Inc., Levels Health Inc., Fountain Life LLC, Viome Life Sciences Inc., Nightingale Health Plc, Elysium Health Inc., TruDiagnostic Inc., Occuity Limited, InsideTracker Inc., Gero PTE. Ltd., Chronomics Limited, BioAro Inc., Circulate Health Inc., MediPredict Medicine Pvt. Ltd., Prenuvo Inc., Longevity Care Partners, Genomind, ADNAB Inc.
North America was the dominating region in the precision longevity and aging technology (agetech) diagnostics market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the precision longevity and aging technology (agetech) diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision longevity and aging technology (agetech) diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary
2. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Characteristics
3. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Supply Chain Analysis
4. Global Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Trends And Strategies
5. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Analysis Of End Use Industries
7. Global Precision Longevity And Aging Technology (AgeTech) Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Precision Longevity And Aging Technology (AgeTech) Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Segmentation
10. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Regional And Country Analysis
11. Asia-Pacific Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
12. China Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
13. India Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
14. Japan Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
15. Australia Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
16. Indonesia Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
17. South Korea Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
18. Taiwan Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
19. South East Asia Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
20. Western Europe Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
21. UK Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
22. Germany Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
23. France Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
24. Italy Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
25. Spain Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
26. Eastern Europe Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
27. Russia Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
28. North America Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
29. USA Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
30. Canada Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
31. South America Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
32. Brazil Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
33. Middle East Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
34. Africa Precision Longevity And Aging Technology (AgeTech) Diagnostics Market
36. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Competitive Landscape And Company Profiles
37. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Other Major And Innovative Companies
41. Precision Longevity And Aging Technology (AgeTech) Diagnostics Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Precision Longevity And Aging Technology (AgeTech) Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses precision longevity and aging technology (agetech) diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for precision longevity and aging technology (agetech) diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision longevity and aging technology (agetech) diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:
1) By Service Type: Biological Age Testing And Epigenetic Clocks; Multi Cancer Early Detection Tests; Metabolomics And Proteomics Panels; Longevity Clinic Programs; Personalized Wellness Artificial Intelligence Platforms2) By Technology: Liquid Biopsy; Artificial Intelligence Powered Biomarker Analysis; Wearable Continuous Monitoring; Genomic Sequencing
3) By Application Area: Biological Age Assessment; Age Related Disease Risk Prediction; Longevity And Healthspan Tracking; Personalized Preventive Interventions
4) By End User: Hospitals And Clinics; Longevity Centers; Diagnostic Laboratories; Research Institutions; Home Healthcare Providers; Corporate Wellness Centers; Academic Institutions; Individual Consumers
Subsegments:
1) By Biological Age Testing And Epigenetic Clocks: Deoxyribonucleic Acid Methylation Age Assessment; Cellular Senescence Analysis; Telomere Length Measurement; Functional Aging Biomarker Testing; Personalized Longevity Risk Profiling2) By Multi Cancer Early Detection Tests: Blood Based Cancer Screening Tests; Circulating Tumor Biomarker Detection; Genetic Cancer Risk Testing; Organ Specific Cancer Detection Tests; Preventive Oncology Screening Services
3) By Metabolomics And Proteomics Panels: Comprehensive Metabolic Profiling; Protein Biomarker Analysis; Nutritional Biomarker Assessment; Cellular Function Monitoring; Personalized Metabolic Health Evaluation
4) By Longevity Clinic Programs: Preventive Health Optimization Programs; Personalized Anti Aging Care Plans; Healthy Lifespan Extension Programs; Integrated Diagnostic Assessment Services; Precision Wellness Management Programs
5) By Personalized Wellness Artificial Intelligence Platforms: Digital Health Recommendation Platforms; Predictive Health Risk Analytics; Personalized Lifestyle Optimization Tools; Continuous Health Monitoring Platforms; Intelligent Preventive Care Systems
Companies Mentioned: Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Illumina Inc.; Everly Health Inc.; Neko Health AB; Genova Diagnostics Inc.; Human Longevity Inc.; Levels Health Inc.; Fountain Life LLC; Viome Life Sciences Inc.; Nightingale Health Plc; Elysium Health Inc.; TruDiagnostic Inc.; Occuity Limited; InsideTracker Inc.; Gero PTE. Ltd.; Chronomics Limited; BioAro Inc.; Circulate Health Inc.; MediPredict Medicine Pvt. Ltd.; Prenuvo Inc.; Longevity Care Partners; Genomind; ADNAB Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Illumina Inc.
- Everly Health Inc.
- Neko Health AB
- Genova Diagnostics Inc.
- Human Longevity Inc.
- Levels Health Inc.
- Fountain Life LLC
- Viome Life Sciences Inc.
- Nightingale Health Plc
- Elysium Health Inc.
- TruDiagnostic Inc.
- Occuity Limited
- InsideTracker Inc.
- Gero PTE. Ltd.
- Chronomics Limited
- BioAro Inc.
- Circulate Health Inc.
- MediPredict Medicine Pvt. Ltd.
- Prenuvo Inc.
- Longevity Care Partners
- Genomind
- ADNAB Inc.
